Eden Research plc (LON:EDEN – Get Free Report) shares were up 2.8% during mid-day trading on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Price Performance
The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The company has a market capitalization of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The firm has a fifty day moving average of GBX 3.88 and a 200 day moving average of GBX 4.01.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Are Dividend Contenders? Investing in Dividend Contenders
- What Does the Future Hold for Eli Lilly?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.